The Birmingham office of professional services firm, KPMG, raised over £11,000 for Cure Leukaemia last year. Due to Cure Leukaemia’s relationship with pharmaceutical companies, KPMG’s fundraising can leverage over £110,000 in potentially life-saving drug and transplant treatments for blood cancer patients in the Midlands.
Over 1000 employees at KPMG’s Birmingham office were involved in a number of Cure Leukaemia’s events throughout 2015 including the Brindleyplace Dragonboat Festival, Glynn Purnell’s Friday Night Kitchen and the Great Birmingham Run.
Cure Leukaemia recently announced £3million capital fundraising campaign to develop the Centre for Clinical Haematology (CCH) at the Queen Elizabeth Hospital, Birmingham to establish the Birmingham Institute for Haematology (BIH). The BIH will significantly increase the Centre’s ability to open clinical trials and amplify patient benefit. The BIH will not only hasten progress towards establishing effective treatments for all blood cancers within our lifetime but also immediately increase the number of lives saved in the process.
KPMG’s staff will support Cure Leukaemia once again in 2016 and their fundraising will go towards the establishment of the BIH.
Andy Argyle, partner at KPMG said:
“We all thoroughly enjoyed fundraising for Cure Leukaemia throughout 2015 and to raise such a fantastic figure is testament to the efforts from the whole workforce.
We are vocal in our backing of Birmingham as a centre for medical excellence, with the Life Sciences campus being a hub for expertise and employment.
Our support for Cure Leukaemia feels like a natural progression to being able to practically help fund the search to find a cure for blood cancer.
We look forward to supporting Professor Charlie Craddock CBE and his team once again in 2016.”
Jackie Kelly, Cure Leukaemia’s Head of Corporate Partnerships, said:
“We were thrilled with the fantastic support KPMG gave the charity last year and we look forward to working with the company again in 2016.
Partnerships with global businesses such as KPMG not only directly benefit blood cancer patients in the Midlands through fundraising, but also help raise the profile of the charity.
I hope more Birmingham businesses consider supporting Cure Leukaemia in the future.”
Cure Leukaemia's £1m Centre Appeal 2017